Indigestion Completed Phase 3 Trials for Lidocaine (DB00281)

Also known as: Dyspepsia

IndicationStatusPhase
DBCOND0031004 (Indigestion)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00521703Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in ChildrenTreatment